Delivery Order SPE2DB20D2104-SPE2DB23FR83X
Award Date 1/18/23
Potential Completion Date 1/19/23
Potential Value $27K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Xifaxan 550 mg tablets, a prescription medication used to treat certain gastrointestinal conditions. The total ceiling value of the contract is $3,591.66, with an ultimate completion date of April 26, 2023. The contract is not designated as a set-aside award....
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Xifaxan 550 mg tablets. The total ceiling value of the contract is $11,682.85 and the period of performance runs through March 18, 2024. This delivery order appears to be part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which serves as the...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $3,908.59 and provides Xifaxan 550 mg tablets to support military treatment programs and facilities. The delivery order falls under a larger indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 awarded to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xifaxan 550 mg tablets, a prescription medication. The fixed-price contract has a ceiling value of $16,988.59 and a performance period ending on May 14, 2025. This contract is not set aside for any special designation. AmerisourceBergen Drug Corp is the prime contractor and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Xifaxan 550 mg tablets. The contract is a firm fixed-price, Indefinite Delivery Contract (IDC) with a ceiling value of $5,274.15. The order has a period of performance through September 13, 2024, with an award date of September 12, 2024. There is no set-aside designation indicated. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Xifaxan 550 mg tablets. The firm-fixed-price contract has a ceiling value of $1,162.08 and an ultimate completion date of August 7, 2024. It is not designated as a set-aside contract. The award is issued under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,691.88, is for the delivery of Xifaxan 550 mg tablets. This is a Delivery Order contract with a Firm Fixed Price pricing type, with a completion date of December 6, 2023. The contract is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xifaxan 550 mg tablet 60s, a prescription medication. The contract has a ceiling value of $11,293.08 and is a firm fixed price delivery order. The ultimate completion date is June 10, 2025. This contract is not designated as a set-aside and is open to full and open...
- This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Xifaxan 550 mg tablets. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,759.13 and a period of performance through May 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The order is for Xifaxan 550 mg tablets and has a ceiling value of $12,553.49. The contract is a firm fixed-price delivery order with a completion date of December 21, 2023. There is no set-aside designation for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...